Qinghai Spring Medicinal Resources Technology CoLTD operates in the Bituminous coal and lignite--surface sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Qinghai Spring Medicinal Resources Technology CoLTD with three other
coal companies in Asia:
Rosan Resources Holdings Limited
of Hong Kong
sales of 529.88 million Hong Kong Dollars [US$67.52 million]
Vinacomin Mong Duong Coal JSC
(1.44 trillion Dong [US$62.25 million]
Vinacomin NuiBeo Coal JSC
based in Vietnam
(1.49 trillion Dong [US$64.26 million]
Qinghai Spring Medicinal Resources Technology CoLTD reported sales of 470.92 million Chinese Renmimbi (US$69.66 million)
December of 2017.
decrease of 33.5%
versus 2016, when the company's sales were 707.95 million Chinese Renmimbi.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Qinghai Spring Medicinal Resources Technology CoLTD had sales
of 514.26 million Chinese Renmimbi.
Contributing to the drop in overall sales was the 40.1% decline
in Utilization of Medicinal Resources, from 411.87 million Chinese Renmimbi to 246.76 million Chinese Renmimbi.
There were also decreases in sales in
Advertising Business (down 16.5% to 224.35 million Chinese Renmimbi)